393 related articles for article (PubMed ID: 14750576)
1. Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3).
Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
Lepr Rev; 2003 Dec; 74(4):311-8. PubMed ID: 14750576
[TBL] [Abstract][Full Text] [Related]
2. The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2).
Van Brakel WH; Anderson AM; Withington SG; Croft RP; Nicholls PG; Richardus JH; Smith WC
Lepr Rev; 2003 Dec; 74(4):300-10. PubMed ID: 14750575
[TBL] [Abstract][Full Text] [Related]
3. Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials.
Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
Lepr Rev; 2003 Dec; 74(4):319-27. PubMed ID: 14750577
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroids for treating nerve damage in leprosy. A Cochrane review.
van Veen NH; Nicholls PG; Smith WC; Richardus JH
Lepr Rev; 2008 Dec; 79(4):361-71. PubMed ID: 19274983
[TBL] [Abstract][Full Text] [Related]
5. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. III. Neural and other impairments.
Schreuder PA
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):170-81. PubMed ID: 9728449
[TBL] [Abstract][Full Text] [Related]
6. Treatment duration of reversal reaction: a reappraisal. Back to the past.
Naafs B
Lepr Rev; 2003 Dec; 74(4):328-36. PubMed ID: 14750578
[TBL] [Abstract][Full Text] [Related]
7. Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy.
Rao PS; Sugamaran DS; Richard J; Smith WC
Lepr Rev; 2006 Mar; 77(1):25-33. PubMed ID: 16715687
[TBL] [Abstract][Full Text] [Related]
8. Delay in presentation, an indicator for nerve function status at registration and for treatment outcome--the experience of the Bangladesh Acute Nerve Damage Study cohort.
Nicholls PG; Croft RP; Richardus JH; Withington SG; Smith WC
Lepr Rev; 2003 Dec; 74(4):349-56. PubMed ID: 14750580
[TBL] [Abstract][Full Text] [Related]
9. Unexplained delayed nerve impairment in leprosy after treatment.
Rosenberg NR; Faber WR; Vermeulen M
Lepr Rev; 2003 Dec; 74(4):357-65. PubMed ID: 14750581
[TBL] [Abstract][Full Text] [Related]
10. A field trial of detection and treatment of nerve function impairment in leprosy--report from national POD pilot project.
Jiang J; Watson JM; Zhang GC; Wei XY
Lepr Rev; 1998 Dec; 69(4):367-75. PubMed ID: 9927809
[TBL] [Abstract][Full Text] [Related]
11. Impairments and Hansen's disease control in Rondônia state, Amazon region of Brazil.
De Oliveira CR; De Alencar Mde J; De Sena Neto SA; Lehman LF; Schreuder PA
Lepr Rev; 2003 Dec; 74(4):337-48. PubMed ID: 14750579
[TBL] [Abstract][Full Text] [Related]
12. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.
van Brakel WH; Nicholls PG; Das L; Barkataki P; Suneetha SK; Jadhav RS; Maddali P; Lockwood DN; Wilder-Smith E; Desikan KV
Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033
[TBL] [Abstract][Full Text] [Related]
13. Effect of Steroid Prophylaxis on Nerve Function Impairment in Multi-bacillary Leprosy Patients on MDT-MB.
Sahay G; Kar HK; Gupta R
Indian J Lepr; 2015; 87(3):133-43. PubMed ID: 26999985
[TBL] [Abstract][Full Text] [Related]
14. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up.
Richardus JH; Nicholls PG; Croft RP; Withington SG; Smith WC
Int J Epidemiol; 2004 Apr; 33(2):337-43. PubMed ID: 15082636
[TBL] [Abstract][Full Text] [Related]
15. A clinical prediction rule for nerve function impairment in leprosy patients-revisited after 5 years of follow-up.
Croft RP; Nicholls PG; Steyerberg EW; Richardus JH; Withington SG; Smith WC
Lepr Rev; 2003 Mar; 74(1):35-41. PubMed ID: 12669931
[TBL] [Abstract][Full Text] [Related]
16. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.
Van Brakel WH; Nicholls PG; Das L; Barkataki P; Maddali P; Lockwood DN; Wilder-Smith E
Lepr Rev; 2005 Dec; 76(4):277-95. PubMed ID: 16411508
[TBL] [Abstract][Full Text] [Related]
17. The effect of corticosteroid usage on the bacterial killing, clearance and nerve damage in leprosy: a prospective cohort study: part 1--study design and baseline findings of 400 untreated multibacillary patients.
Khambati FA; Shetty VP; Ghate SD; Capadia GD; Pai VV; Ganapati R
Lepr Rev; 2008 Jun; 79(2):134-53. PubMed ID: 18711936
[TBL] [Abstract][Full Text] [Related]
18. Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols.
Wagenaar I; Brandsma W; Post E; van Brakel W; Lockwood D; Nicholls P; Saunderson P; Smith C; Wilder-Smith E; Richardus JH
BMC Neurol; 2012 Dec; 12():159. PubMed ID: 23249098
[TBL] [Abstract][Full Text] [Related]
19. Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1).
Smith WC; Anderson AM; Withington SG; van Brakel WH; Croft RP; Nicholls PG; Richardus JH
BMJ; 2004 Jun; 328(7454):1459. PubMed ID: 15159285
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
